Cargando…
Is vascular remodelling in patients with chronic heart failure exaggerated?
BACKGROUND: Vascular remodelling of large arteries increases afterload of the left ventricle. The aim of this study was to analyse whether vascular remodelling and function under laboratory and 24‐hour ambulatory conditions is impaired in patients with chronic heart failure (CHF) independently of ca...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871653/ https://www.ncbi.nlm.nih.gov/pubmed/36193013 http://dx.doi.org/10.1002/ehf2.14174 |
_version_ | 1784877225587245056 |
---|---|
author | Pietschner, Robert Bosch, Agnes Kannenkeril, Dennis Striepe, Kristina Schiffer, Mario Achenbach, Stephan Schmieder, Roland E. Kolwelter, Julie |
author_facet | Pietschner, Robert Bosch, Agnes Kannenkeril, Dennis Striepe, Kristina Schiffer, Mario Achenbach, Stephan Schmieder, Roland E. Kolwelter, Julie |
author_sort | Pietschner, Robert |
collection | PubMed |
description | BACKGROUND: Vascular remodelling of large arteries increases afterload of the left ventricle. The aim of this study was to analyse whether vascular remodelling and function under laboratory and 24‐hour ambulatory conditions is impaired in patients with chronic heart failure (CHF) independently of cardiovascular risk factors. METHODS AND RESULTS: In this monocentric cross‐sectional observational study, 105 patients with CHF and an ejection fraction ≤49% (CHF+) were compared to 118 subjects without CHF (CHF−). After adjustment for age, gender, arterial hypertension, hyperlipidaemia, type 2 diabetes, obesity and smoking, vascular function and structure parameters, as assessed by pulse wave analysis (SphygmoCor) and the UNEX EF device, respectively, between the CHF+ and the CHF− group differed for resting pulse wave velocity (PWV) (P = 0.010), 24‐h ambulatory PWV (P = 0.011), central systolic blood pressure (cSBP) (P = <0.001), 24‐h ambulatory cSBP (P = <0.001), resting central augmentation index (P = 0.002), and brachial intima–media thickness (P = 0.022). In CHF+ patients, higher levels of NT‐proBNP, taken as a marker for the severity of CHF, were related to a higher PWV (r = 0.340, P = <0.001), a higher cSBP (r = 0.292, P = 0.005), and a trend to higher central pulse pressure (cPP) (r = 0.198, P = 0.058), higher 24‐h brachial PP (r = 0.322, P = 0.002), and 24‐h total peripheral resistance (s = 0.227, P = 0.041) after full adjustment for covariates. CONCLUSIONS: In CHF+ patients we observed augmented vascular remodelling and functional impairment compared with CHF− patients independently of cardiovascular risk factors, age, and gender, and the extent of vascular remodelling and impairment was related to the severity of CHF. |
format | Online Article Text |
id | pubmed-9871653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98716532023-01-25 Is vascular remodelling in patients with chronic heart failure exaggerated? Pietschner, Robert Bosch, Agnes Kannenkeril, Dennis Striepe, Kristina Schiffer, Mario Achenbach, Stephan Schmieder, Roland E. Kolwelter, Julie ESC Heart Fail Original Articles BACKGROUND: Vascular remodelling of large arteries increases afterload of the left ventricle. The aim of this study was to analyse whether vascular remodelling and function under laboratory and 24‐hour ambulatory conditions is impaired in patients with chronic heart failure (CHF) independently of cardiovascular risk factors. METHODS AND RESULTS: In this monocentric cross‐sectional observational study, 105 patients with CHF and an ejection fraction ≤49% (CHF+) were compared to 118 subjects without CHF (CHF−). After adjustment for age, gender, arterial hypertension, hyperlipidaemia, type 2 diabetes, obesity and smoking, vascular function and structure parameters, as assessed by pulse wave analysis (SphygmoCor) and the UNEX EF device, respectively, between the CHF+ and the CHF− group differed for resting pulse wave velocity (PWV) (P = 0.010), 24‐h ambulatory PWV (P = 0.011), central systolic blood pressure (cSBP) (P = <0.001), 24‐h ambulatory cSBP (P = <0.001), resting central augmentation index (P = 0.002), and brachial intima–media thickness (P = 0.022). In CHF+ patients, higher levels of NT‐proBNP, taken as a marker for the severity of CHF, were related to a higher PWV (r = 0.340, P = <0.001), a higher cSBP (r = 0.292, P = 0.005), and a trend to higher central pulse pressure (cPP) (r = 0.198, P = 0.058), higher 24‐h brachial PP (r = 0.322, P = 0.002), and 24‐h total peripheral resistance (s = 0.227, P = 0.041) after full adjustment for covariates. CONCLUSIONS: In CHF+ patients we observed augmented vascular remodelling and functional impairment compared with CHF− patients independently of cardiovascular risk factors, age, and gender, and the extent of vascular remodelling and impairment was related to the severity of CHF. John Wiley and Sons Inc. 2022-10-03 /pmc/articles/PMC9871653/ /pubmed/36193013 http://dx.doi.org/10.1002/ehf2.14174 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Pietschner, Robert Bosch, Agnes Kannenkeril, Dennis Striepe, Kristina Schiffer, Mario Achenbach, Stephan Schmieder, Roland E. Kolwelter, Julie Is vascular remodelling in patients with chronic heart failure exaggerated? |
title | Is vascular remodelling in patients with chronic heart failure exaggerated? |
title_full | Is vascular remodelling in patients with chronic heart failure exaggerated? |
title_fullStr | Is vascular remodelling in patients with chronic heart failure exaggerated? |
title_full_unstemmed | Is vascular remodelling in patients with chronic heart failure exaggerated? |
title_short | Is vascular remodelling in patients with chronic heart failure exaggerated? |
title_sort | is vascular remodelling in patients with chronic heart failure exaggerated? |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871653/ https://www.ncbi.nlm.nih.gov/pubmed/36193013 http://dx.doi.org/10.1002/ehf2.14174 |
work_keys_str_mv | AT pietschnerrobert isvascularremodellinginpatientswithchronicheartfailureexaggerated AT boschagnes isvascularremodellinginpatientswithchronicheartfailureexaggerated AT kannenkerildennis isvascularremodellinginpatientswithchronicheartfailureexaggerated AT striepekristina isvascularremodellinginpatientswithchronicheartfailureexaggerated AT schiffermario isvascularremodellinginpatientswithchronicheartfailureexaggerated AT achenbachstephan isvascularremodellinginpatientswithchronicheartfailureexaggerated AT schmiederrolande isvascularremodellinginpatientswithchronicheartfailureexaggerated AT kolwelterjulie isvascularremodellinginpatientswithchronicheartfailureexaggerated |